press release Mediaspace 5/2/24 press release Mediaspace 5/2/24 Luxa Biotechnology Receives $4 Million Grant for Clinical Trial of Dry AMD Treatment Read More press release Mediaspace 1/23/24 press release Mediaspace 1/23/24 Luxa Biotechnology announces paper on 'Identification of Biomarkers for Diversity and Transplantation Efficacy of Retinal Pigment Epithelial Cells' by Dr. Sally Temple. Read More press release Mediaspace 1/23/24 press release Mediaspace 1/23/24 Luxa Biotechnology to Provide Update on Clinical Trial of Retinal Pigmented Epithelium Stem Cell (RPESC) Technology for Treatment of Dry Age-Related Macular Degeneration in Panel Session at ARVO Read More press release Mediaspace 1/23/24 press release Mediaspace 1/23/24 The Report of the Annual Meeting hosted by the National Eye Institute in the United States has been released Read More press release Mediaspace 1/23/24 press release Mediaspace 1/23/24 Sally Temple, Ph.D., named to National Academy of Medicine Read More Newer Posts Older Posts
press release Mediaspace 5/2/24 press release Mediaspace 5/2/24 Luxa Biotechnology Receives $4 Million Grant for Clinical Trial of Dry AMD Treatment Read More
press release Mediaspace 1/23/24 press release Mediaspace 1/23/24 Luxa Biotechnology announces paper on 'Identification of Biomarkers for Diversity and Transplantation Efficacy of Retinal Pigment Epithelial Cells' by Dr. Sally Temple. Read More
press release Mediaspace 1/23/24 press release Mediaspace 1/23/24 Luxa Biotechnology to Provide Update on Clinical Trial of Retinal Pigmented Epithelium Stem Cell (RPESC) Technology for Treatment of Dry Age-Related Macular Degeneration in Panel Session at ARVO Read More
press release Mediaspace 1/23/24 press release Mediaspace 1/23/24 The Report of the Annual Meeting hosted by the National Eye Institute in the United States has been released Read More
press release Mediaspace 1/23/24 press release Mediaspace 1/23/24 Sally Temple, Ph.D., named to National Academy of Medicine Read More
